Jefferies Financial Group Begins Coverage on Rhythm ... - MarketBeat

Jan 2, 2025 · The Goldman Sachs Group upped their price objective on Rhythm Pharmaceuticals from $59.00 to $66.00 and gave the company a "buy" rating in a research report on Thursday, December 5th. Oppenheimer assumed coverage on shares of Rhythm Pharmaceuticals in a …

$59.00
OFF

Jefferies Financial Group Begins Coverage On Rhythm ... - MarketBeat

1 week from now

marketbeat.com

$80.00
OFF

Rhythm Pharmaceuticals (RYTM) News Today - MarketBeat

1 week from now

Jan 10, 2025 · Jefferies Financial Group initiated coverage on shares of Rhythm Pharmaceuticals in a report on Thursday. They issued a "buy" rating and a $80.00 price objective on the stock. …

marketbeat.com

$80.00
OFF

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Shares Sold By

1 week from now

4 days ago · Canaccord Genuity Group reissued a "buy" rating and issued a $80.00 price target on shares of Rhythm Pharmaceuticals in a report on Tuesday, November 19th. Jefferies …

marketbeat.com

80%
OFF

Jefferies Starts Rhythm Pharmaceuticals With Buy On Obesity

1 week from now

Jan 1, 2025 · Jefferies analyst Dennis Ding initiated coverage of Rhythm Pharmaceuticals (RYTM) with a Buy rating and $80 price target The firm sees an 80%-85% probability of …

nasdaq.com

$80
OFF

Rhythm Pharmaceuticals Initiated With A Buy At Jefferies

1 week from now

Dec 31, 2024 · Jefferies analyst Dennis Ding initiated coverage of Rhythm Pharmaceuticals (RYTM) with a Buy rating and $80 price target Discover the latest stocks recommended by top …

businessinsider.com

$80
OFF

Rhythm Pharmaceuticals Initiated With A Buy At Jefferies

1 week from now

Dec 31, 2024 · Jefferies analyst Dennis Ding initiated coverage of Rhythm Pharmaceuticals (RYTM) with a Buy rating and $80 price target Don't Miss Our New Year's Offers:Discover the …

nasdaq.com

50%
OFF

Rhythm Pharmaceuticals Buy Jefferies Financial Group Inc.

1 week from now

Jan 2, 2025 · The prediction end date can be changed by Jefferies_Financial_ at any time. Jefferies_Financial_ has 50% into this prediction ... Rhythm Pharmaceuticals, Inc. (NASDAQ: …

sharewise.com

39%
OFF

Jefferies Financial Group Begins Coverage On IDACORP (NYSE:IDA)

1 week from now

Sep 20, 2024 · Jefferies Financial Group has initiated coverage on IDACORP (NYSE:IDA), assigning a "hold" rating and a price target suggesting a potential upside of 7.39%. Other …

longportapp.com

$67.00
OFF

Jefferies Financial Group (NYSE:JEF) Hits New 1-Year High

1 week from now

Jan 6, 2025 · UBS Group assumed coverage on Jefferies Financial Group in a research report on Tuesday, September 17th. They issued a "buy" rating and a $67.00 target price for the …

marketbeat.com

$0.91
OFF

Jefferies Financial Group (NYSE:JEF) Announces Earnings

1 week from now

Jan 8, 2025 · Jefferies Financial Group (NYSE:JEF - Get Free Report) issued its quarterly earnings results on Wednesday. The financial services provider reported $0.91 earnings per …

marketbeat.com

$175.00
OFF

Cantor Fitzgerald Begins Coverage On Snowflake (NYSE:SNOW)

1 week from now

21 hours ago · DA Davidson reiterated a "buy" rating and issued a $175.00 target price on shares of Snowflake in a report on Thursday, October 3rd. Jefferies Financial Group increased their …

marketbeat.com

$63.00
OFF

TD Securities Begins Coverage On Enbridge (NYSE:ENB) - MarketBeat

1 week from now

2 days ago · Royal Bank of Canada reissued an "outperform" rating and issued a $63.00 price objective (up previously from $59.00) on shares of Enbridge in a research report on …

marketbeat.com

2%
OFF

JPMorgan Chase & Co. Has $154.15 Million Position In Jefferies ...

1 week from now

Jan 1, 2025 · JPMorgan Chase & Co. boosted its holdings in shares of Jefferies Financial Group Inc. (NYSE:JEF - Free Report) by 7.2% during the 3rd quarter, according to the company in its …

marketbeat.com

$120.00
OFF

Abbott Laboratories (ABT) To Release Earnings On Wednesday

1 week from now

1 day ago · Jefferies Financial Group increased their price target on shares of Abbott Laboratories from $120.00 to $125.00 and gave the stock a "hold" rating in a research report on Thursday, …

marketbeat.com

$35.00
OFF

Tenaris (NYSE:TS) Stock Rating Lowered By Kepler Capital

1 week from now

21 hours ago · Jefferies Financial Group raised Tenaris from a "hold" rating to a "buy" rating and raised their price objective for the stock from $35.00 to $47.00 in a research note on Monday, …

marketbeat.com

FAQs about Jefferies Financial Group Begins Coverage on Rhythm ... - MarketBeat Coupon?

Is marketbeat endorsed by Jefferies Financial Group?

MarketBeat and its parent company are in no way affiliated with or endorsed by Jefferies Financial Group. Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. If you’ve been investing in the major indexes for the last 20 years, you may need a new strategy. ...

Can Oppenheimer buy Rhythm Pharmaceuticals (rhythm)?

Oppenheimer started coverage on Rhythm Pharmaceuticals in a report on Friday, December 20th. They set an “outperform” rating and a $76.00 price target on the stock. Canaccord Genuity Group reaffirmed a “buy” rating and set a $80.00 target price on shares of Rhythm Pharmaceuticals in a research note on Tuesday, November 19th. ...

Is Rhythm Pharmaceuticals a good stock to buy?

Bank of America boosted their target price on shares of Rhythm Pharmaceuticals from $48.00 to $52.00 and gave the stock a “neutral” rating in a report on Monday, October 14th. JMP Securities restated a “market outperform” rating and issued a $75.00 target price on shares of Rhythm Pharmaceuticals in a report on Monday, December 23rd. ...

Which hedge funds have changed their positions in Rhythm Pharmaceuticals?

Hedge funds and other institutional investors have recently made changes to their positions in the business. ORG Wealth Partners LLC acquired a new position in shares of Rhythm Pharmaceuticals in the third quarter valued at about $63,000. Quest Partners LLC grew its position in shares of Rhythm Pharmaceuticals by 513.3% during the 2nd quarter. ...

Who owns Rhythm Pharmaceuticals?

Mirae Asset Global Investments Co. Ltd. increased its holdings in shares of Rhythm Pharmaceuticals by 21.5% during the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 2,211 shares of the company’s stock worth $114,000 after purchasing an additional 391 shares during the period. ...

How many EPs will Rhythm Pharmaceuticals post?

Equities analysts expect that Rhythm Pharmaceuticals will post -4.34 EPS for the current fiscal year. In related news, EVP Jennifer Kayden Lee sold 66,861 shares of the firm’s stock in a transaction on Monday, November 11th. The stock was sold at an average price of $66.33, for a total transaction of $4,434,890.13. ...